Pressure BioSciences to Expand on Recent Announcement of Over $1,000,000 in Orders Received by its New Eco-Friendly Agrochem Subsidiary in First Month of Operations

August 17, 2021 10:45 AM

Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, InteractivePBI Agrochem Update, Followed by a Q&A Session, on Wednesday, August 18, 2021SOUTH EASTON, MA / ACCESSWIRE / August 17, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and services to the worldwide life sciences,...

Read more

Woodward Pharma Services LLC Acquires LOVAZA(R) Capsules

August 17, 2021 10:30 AM

WIXOM, MI / ACCESSWIRE / August 17, 2021 / Woodward Pharma Services LLC ("Woodward"), a Michigan-based specialty pharmaceutical company focused on acquiring, licensing and commercializing branded and generic products for the U.S. market, announces the acquisition of LOVAZA® (LO-VEY-ZA) soft gelatin capsules.LOVAZA® (omega-3-acid ethyl esters) capsules are indicated as an adjunct to diet to reduce triglyceride levels in adult patients...

Read more

Thermic Science Files 2021 Second Quarter Financials Ending June 30, 2021, Continuing to Bring the Company in Compliance with the OTC Market to Pink Current Status and No Shell Designation by Filing its Financials & Business Activities Reporting Requirements

August 17, 2021 10:10 AM

NASHVILLE, TN / ACCESSWIRE / August 17, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka Endocan Corporation. (WKN:A1W61J) (ISIN:US29271J1097) (OTC:ENDO), is pleased to announce the unaudited interim consolidated financial results of the Company for the second quarter ended June 30, 2021. The full version of the financial statements and the management discussion and analysis can be viewed...

Read more

Applied UV Reports Second Quarter 2021 Results

August 17, 2021 7:00 AM

Accelerated global commercial strategy for infection control products via partnerships and distributionAirocide® air purifications installations in hospitals, museums, wineries, and school systemsIndependent lab results confirmed SteriLumen's Lumicide™Ribbon kills SARS-CoV-2 (COVID-19 Virus)Hotel & hospitality demand for MunnWorks subsidiary recoveringContinued focus on inorganic growth strategy via synergistic...

Read more

Wuhan General Group Launches M2Bio Labs in Hout Bay, South Africa

August 16, 2021 9:15 AM

CAPE TOWN, SA / ACCESSWIRE / August 16, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research, is pleased to announce the following corporate update:M2Bio Sciences launches M2Bio Labs alongside the distinguished Bay Harbour Market in Hout Bay. This picturesque setting encompasses 7500 square feet which will house the...

Read more

Xenetic Biosciences, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update

August 13, 2021 8:05 AM

Continued execution on XCART TM pre-clinical development plan and progress toward IND-enabling studies Strong royalty growth with PolyXen® platform technology Bolstered cash position with recently completed $12.5 million private placement FRAMINGHAM, MA / ACCESSWIRE / August 13, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a...

Read more

Edesa Biotech Reports Fiscal 3rd Quarter 2021 Financial Results

August 13, 2021 7:50 AM

TORONTO, ON / ACCESSWIRE / August 13, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported financial results for the three and nine months ended June 30, 2021 and provided an update on its business.During the quarter, the company achieved key interim milestones for both of its lead product candidates, EB05 and EB01. Independent monitoring boards...

Read more

Dyadic Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress

August 12, 2021 4:00 PM

Executed binding term sheet with Sorrento Therapeutics (Nasdaq:SRNE) to outlicense C1 protein production platform for the development and commercialization of vaccines, therapeutic antibodies, protein therapeutics, and diagnostics for coronaviruses, including DYAI-100, Dyadic's lead COVID-19 vaccine candidateNew collaboration with India's Syngene International to develop a COVID-19 vaccine candidateNew co-development collaboration with South...

Read more

Applied UV Continues Successful Installation of Airocide(R) Systems at U.S. Army's Aberdeen Proving Ground

August 12, 2021 9:25 AM

Since 2020, over 100 Airocide® units installed to help critical U.S military facility remain open and protect staff and visitorsMOUNT VERNON, NY / ACCESSWIRE / August 12, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens...

Read more

EV Biologics Briefs Shareholders on Market Cap Peer Comparison

August 12, 2021 9:00 AM

NASHVILLE, TN / ACCESSWIRE / August 12, 2021 / EV Biologics Corp, OTC Pink:YECO, today briefed shareholders on its current value compared to other public biotechnology companies in its peer group.Please view the chart at: https://www.evbiologics.com/marketcap/.CEO Daniel Mckinney commented: 'Our market cap is less than half that of our closest listed peer. Our goal is to continue to build value and become the largest listed company by market cap...

Read more

Pressure BioSciences New Eco-Friendly Agrochem Subsidiary Receives Over $1,000,000 in Orders in First Month of Operations

August 12, 2021 8:31 AM

PBI Agrochem Integration into the Sales Channels of Its Planned Asset Acquisition of a Global, Environmentally Responsible Agrochem Company is Expected to Result in a Significant Q3 2021 ImpactSOUTH EASTON, MA / ACCESSWIRE / August 12, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the...

Read more

Phyto Extractions Inc. Announces Proposed Acquisition of PerceiveMD, a Multidisciplinary Centre for Medical Cannabis and Psychedelic Therapies

August 11, 2021 4:15 PM

LANGLEY, BC / ACCESSWIRE / August 11, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(FRA:D2EP) (“Phyto Extractions™” or the “Company”) is pleased to announce that it has entered into a share purchase agreement dated August 10, 2021 (the “Share Purchase Agreement”) pursuant to which the Company has agreed to acquire, indirectly through its wholly-owned subsidiary Adastra...

Read more

Applied UV Continues Successful Installation of Airocide(R) Systems at Multiple Wineries in Europe

August 10, 2021 9:40 AM

Hungary's leading wine technology company, Cellarius, has recently installed additional Airocide® units to help wineries remain open and protect staff, visitors, and winemaking operationsMOUNT VERNON, NY / ACCESSWIRE / August 10, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic...

Read more

BioLargo Q2 2021 Earnings Results Webcast and Conference Call Wednesday, August 17, 2021 - 11:00 AM Eastern Time

August 10, 2021 7:15 AM

WESTMINSTER, CA / ACCESSWIRE / August 10, 2021 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, will host an investor webcast and conference call on Wednesday August 17, 2021, at 8:00 am PST / 11:00 am EST, open to the public, to review the company's financial results, discuss recent events, and conduct a question-and-answer session.The webcast, accompanying presentation...

Read more

Applied UV to Host Second Quarter 2021 Conference Call on August 17th

August 9, 2021 4:30 PM

MOUNT VERNON, NY / ACCESSWIRE / August 9, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will be hosting an investor conference call and live webcast on...

Read more

EV Biologics NFT Dividend Information

August 9, 2021 9:00 AM

NASHVILLE, TN / ACCESSWIRE / August 9, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT Warrant Dividend.Attached is a preliminary image from the 3D animation still under development that will be issued as an NFT dividendDaniel Mckinney CEO said: "this NFT will capture the stunning visual quality inherent in many biological systems, as in this artistic rendering of a fluorescent micrograph of...

Read more

Wuhan General Group Updates on Third Scientific Paper Published on Psychedelics

August 5, 2021 9:25 AM

CAPE TOWN, SA / ACCESSWIRE / August 5, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research, is pleased to announce the following corporate update:The research team funded by Wuhan General Group has successfully published a third paper on psychedelic science. The paper entitled "Anti-Inflammatory Effects of Four...

Read more

Hillstream BioPharma and Minotaur Therapeutics Sign Term Sheet to Advance Next-Generation Targeted Knob Biologics for Undruggable Targets

August 5, 2021 8:30 AM

Development partnership expected to capitalize upon tumor targeting Quatramersand novel "Knob" biologicsKnob biologics with ultra-long CDRs could be effective against undruggable targetsBRIDGEWATER, NJ / ACCESSWIRE / August 5, 2021 / Hillstream BioPharma, Inc. ("Hillstream", the "Company") today announced the signing of a non-binding term sheet with Minotaur Therapeutics ("Minotaur") to advance the development of the next generation targeted...

Read more

Pressure BioSciences Unveils Aggressive Growth Plan and Goals for Second Half 2021; Company Marches Toward UST Commercial Release, Up-listing, and Profitability

August 5, 2021 7:31 AM

Company's Strong First Half 2021 Viewed as Launch Pad for Accelerating Second Half and Growth Trajectory, Propelled by Multiple Platform Technologies Building Market TractionSOUTH EASTON, MA / ACCESSWIRE / August 5, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide...

Read more

ITOCO welcomes Mr. Xavier Eyamba as Director of its African Management and Development Team, Carbon Credits

August 4, 2021 8:00 AM

TORONTO, ON / ACCESSWIRE / August 4, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to announce that Mr. Xavier Eyamba has joined the firm as Director of its African Management and Development Team, Carbon Credits and Capture.Mr. Eyamba has over 25 years of experience supporting cross-functional teams for results-driven cutting-edge technology solutions to address the Environment, Greenhouse-gas emissions reduction across the Agriculture, Housing,...

Read more